Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
British Journal of Hospital Medicine (London, England : 2005)
|
January 25, 2025
Risk Assessment Prior to Cardiotoxic Anticancer Therapies in 7 Steps
Jieli Tong, Isabelle Senechal, Sivatharshini Ramalingam, et al.
Presse Medicale (Paris, France : 1983)
|
November 23, 2025
Immunotherapy and the heart: Understanding the cardiovascular risks of immune checkpoint inhibitors
Maria Sol Andres, Maria Clara Llamedo, Sivatharshini Ramalingam, et al.
Cardio-Oncology (London, England)
|
April 11, 2024
Cancer therapy related cardiac dysfunction as a result of Panitumumab
Isabelle Senechal, Nikolaos Vogiatzakis, Maria Sol Andres, et al.
Cardio-Oncology (London, England)
|
August 22, 2024
Complementary use of cardiac magnetic resonance and 18 F-FDG positron emission tomography imaging in suspected immune checkpoint inhibitor myocarditis
Jieli Tong, Nikolaos Vogiatzakis, Maria Sol Andres, et al.
Current Oncology Reports
|
September 24, 2024
Risk Stratification, Screening and Treatment of BRAF/MEK Inhibitors-Associated Cardiotoxicity
Isabelle Senechal, Maria Sol Andres, Jieli Tong, et al.
Cardio-Oncology (London, England)
|
March 8, 2024
Late cardiotoxicity related to HER2-targeted cancer therapy
Isabelle Senechal, Maria Sol Andres, Jieli Tong, et al.
The American Journal of Cardiology
|
October 5, 2023
Clinical Utility and Prognostic Value of Coronary Computed Tomography Angiography in Patients With Cancer
Muhummad Sohaib Nazir, Theodore Murphy, Nana Poku, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
June 30, 2025
Chronic Obstructive Pulmonary Disease and the Management of Cardiopulmonary Risk in the UK: A Systematic Literature Review and Modified Delphi Study
Dinesh Shrikrishna, John Steer, Beverley Bostock, et al.
Cardio-Oncology (London, England)
|
November 24, 2022
The spectrum of cardiovascular complications related to immune-checkpoint inhibitor treatment : Including myocarditis and the new entity of non inflammatory left ventricular dysfunction
Maria Sol Andres, Sivatharshini Ramalingam, Stuart D Rosen, et al.
JACC. Cardiooncology
|
October 31, 2024
Cardiovascular Considerations Before Cancer Therapy: Gaps in Evidence and <i>JACC: CardioOncology</i> Expert Panel Recommendations
Zahra Raisi-Estabragh, Alexandra C Murphy, Sivatharshini Ramalingam, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
British Journal of Hospital Medicine (London, England : 2005)
|
January 25, 2025
Risk Assessment Prior to Cardiotoxic Anticancer Therapies in 7 Steps
Jieli Tong, Isabelle Senechal, Sivatharshini Ramalingam, et al.
Presse Medicale (Paris, France : 1983)
|
November 23, 2025
Immunotherapy and the heart: Understanding the cardiovascular risks of immune checkpoint inhibitors
Maria Sol Andres, Maria Clara Llamedo, Sivatharshini Ramalingam, et al.
Cardio-Oncology (London, England)
|
April 11, 2024
Cancer therapy related cardiac dysfunction as a result of Panitumumab
Isabelle Senechal, Nikolaos Vogiatzakis, Maria Sol Andres, et al.
Cardio-Oncology (London, England)
|
August 22, 2024
Complementary use of cardiac magnetic resonance and 18 F-FDG positron emission tomography imaging in suspected immune checkpoint inhibitor myocarditis
Jieli Tong, Nikolaos Vogiatzakis, Maria Sol Andres, et al.
Current Oncology Reports
|
September 24, 2024
Risk Stratification, Screening and Treatment of BRAF/MEK Inhibitors-Associated Cardiotoxicity
Isabelle Senechal, Maria Sol Andres, Jieli Tong, et al.
Cardio-Oncology (London, England)
|
March 8, 2024
Late cardiotoxicity related to HER2-targeted cancer therapy
Isabelle Senechal, Maria Sol Andres, Jieli Tong, et al.
The American Journal of Cardiology
|
October 5, 2023
Clinical Utility and Prognostic Value of Coronary Computed Tomography Angiography in Patients With Cancer
Muhummad Sohaib Nazir, Theodore Murphy, Nana Poku, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
June 30, 2025
Chronic Obstructive Pulmonary Disease and the Management of Cardiopulmonary Risk in the UK: A Systematic Literature Review and Modified Delphi Study
Dinesh Shrikrishna, John Steer, Beverley Bostock, et al.
Cardio-Oncology (London, England)
|
November 24, 2022
The spectrum of cardiovascular complications related to immune-checkpoint inhibitor treatment : Including myocarditis and the new entity of non inflammatory left ventricular dysfunction
Maria Sol Andres, Sivatharshini Ramalingam, Stuart D Rosen, et al.
JACC. Cardiooncology
|
October 31, 2024
Cardiovascular Considerations Before Cancer Therapy: Gaps in Evidence and <i>JACC: CardioOncology</i> Expert Panel Recommendations
Zahra Raisi-Estabragh, Alexandra C Murphy, Sivatharshini Ramalingam, et al.
Page
of 2